Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

12.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.9K
Conserved Binding Sites01:49

Conserved Binding Sites

4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
Protein-protein Interfaces02:04

Protein-protein Interfaces

12.6K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.6K
Protein Networks02:26

Protein Networks

4.0K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.0K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

13.0K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
13.0K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

3.1K
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Profiling fungal secondary metabolites with anti-leishmanial activity: an integrated in silico and in vitro study.

Scientific reports·2026
Same author

Novel imidazo[1,2-a]pyridine-based α-glucosidase inhibitors: synthesis, biological evaluations, and computational studies.

Scientific reports·2026
Same author

Potent and selective α-glucosidase inhibition by coumarin-triazole conjugates: design, <i>in vivo</i> evaluation, and computational insights.

RSC advances·2026
Same author

Computational design, synthesis and biological evaluation of novel pyridinone derivatives as NNRTIs.

Scientific reports·2026
Same author

Exosomes as Advanced Nanocarriers: Overcoming the Blood-Brain Barrier for Targeted Therapeutic Delivery in Neurodegenerative Diseases.

Current drug delivery·2026
Same author

Rethinking MS Therapeutics: From Disease Pathogenesis Mechanisms to AI-Driven Drug Discovery.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology·2026

Related Experiment Video

Updated: Jul 27, 2025

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.9K

A GU-Net-Based Architecture Predicting Ligand-Protein-Binding Atoms.

Fatemeh Nazem1,2, Fahimeh Ghasemi2, Afshin Fassihi3

  • 1Department of Bioelectrics and Biomedical Engineering, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Journal of Medical Signals and Sensors
|June 9, 2023
PubMed
Summary

This study introduces GU-Net, a graph convolutional neural network for predicting protein binding sites. GU-Net accurately identifies more pockets with precise shapes than random forest classifiers, advancing drug discovery.

Keywords:
Graph convolutional neural networkpoint cloud semantic segmentationprotein–ligand-binding sitesthree-dimensional U-Net model

More Related Videos

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.7K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.3K

Related Experiment Videos

Last Updated: Jul 27, 2025

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.9K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.7K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.3K

Area of Science:

  • Computational biology
  • Structural bioinformatics
  • Drug discovery

Background:

  • Accurate prediction of protein binding sites is crucial for designing novel drug antagonists and inhibitors.
  • Convolutional neural networks (CNNs) show promise for predicting protein binding sites.
  • This research focuses on optimizing neural networks for 3D non-Euclidean data, specifically protein structures.

Purpose of the Study:

  • To develop and evaluate an optimized neural network model for predicting protein binding sites using 3D structural data.
  • To compare the performance of the proposed model against existing methods like random forest classifiers.
  • To enhance the accuracy and efficiency of identifying potential drug targets on protein surfaces.

Main Methods:

  • A graph neural network model, GU-Net, was developed utilizing graph convolutional operations.
  • 3D protein structures were represented as graphs, with atomic features serving as node attributes.
  • The GU-Net model's predictions were benchmarked against a random forest (RF) classifier using a novel data representation.

Main Results:

  • GU-Net demonstrated superior performance in predicting protein binding pockets compared to the random forest classifier.
  • The model accurately identified a greater number of pockets with precise shapes.
  • Extensive experiments across diverse datasets validated the robustness and effectiveness of GU-Net.

Conclusions:

  • The developed GU-Net model offers a significant advancement in modeling protein structures for drug design.
  • This work contributes to enhanced knowledge in proteomics and provides deeper insights into the drug discovery pipeline.
  • Future research can build upon GU-Net for more sophisticated protein structure analysis and therapeutic development.